glutathione and triple negative breast cancer Comprehensive single-cell metabolic profiling identifies targets to sensitize triple-negative to chemo-immunotherapy: Cell Reports Medicine Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Metabolic reprogramming in triple negative breast cancer Cancer Biology & Medicine Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



